Rio Grande Urology

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Prostate cancer4 trials

Phase

• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials

Lead sponsor

• Novartis Pharmaceuticals3 trials
• Boston Scientific Corporation1 trial

Running trials

• Recruiting

  A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

  NCT07226986· Phase 1/2· Novartis Pharmaceuticals· Source

  Contact: Paola Delgado

• Active, not recruiting

  SpaceIT Hydrogel System for Perirectal Spacing

  NCT06451614· Boston Scientific Corporation· Source

• Recruiting

  An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

  NCT05939414· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Paola Delgado

• Active, not recruiting

  A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

  NCT05849298· Phase 2· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer2 recruiting